Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

Bullboard Posts

Comment by ebrie014on Jan 23, 2018 2:51pm

82 Views

Post# 27418182

RE:$.97 offer - did we eat through the seller?

I tend to agree.

Some large volume on the buyside today 200K+ in volume....

I think this will finally be the year where we start seeing some appreciation in the share price as we move towards FDA approval/US launch. As the company releases good news on the trials the market will slowly start to notice the evident path to an FDA approval and a huge new market... I personally expect them to be taken out shortly after FDA approval/US launch as the product will have been greatly de-risked for a large pharma product partner to come buy-out.

Bullboard Posts

Debt-free cannabis company set for next stage of growth